Home › Research › Topics › tau-fragments
tau-fragments
4 studies tagged tau-fragments, dated 2008-04-10 to 2024-02-17. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease 2024-02-17
- N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases 2022-08-01
- Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology 2020-02-01
Studies
4 studies carry this tag.
Date range
2008 to 2024
Top journals
- Brain : a journal of neurology 2
- Molecular and cellular neurosciences 1
- Molecular neurodegeneration 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
However, because these biomarkers are strongly associated with the emergence of Aβ pathology, it is difficult to determine the contribution of insoluble tau aggregates to the plasma p-tau signal in blood.
-
After analytical validation, the diagnostic performance of these biomarkers was evaluated in CSF and compared with the Innotest total tau (and as proof of concept, with N-p-tau181 and N-p-tau217) in three clinical cohorts (n = 342 total).
-
57/100
To date, there is no validated fluid biomarker for tau pathology in Alzheimer's disease, with contradictory results from studies evaluating the correlation between phosphorylated tau in CSF with tau PET imaging.
-
Biochemical modifications of tau proteins have been proposed to be among the earliest neurobiological changes in Alzheimer's disease (AD) and correlate better with cognitive symptoms than do beta-amyloid plaques.